The latest version of 3viseon software from 3mensio Medical Imaging gives radiologists and referring physicians real-time access to advanced 3D functionalities, such as color and gray-scale volume and slab renderings and MPR/MIPs, on an off-the-shelf PC.
The latest version of 3viseon software from 3mensio Medical Imaging gives radiologists and referring physicians real-time access to advanced 3D functionalities, such as color and gray-scale volume and slab renderings and MPR/MIPs, on an off-the-shelf PC.
The software was introduced at the 2004 RSNA meeting and released at the 2005 meeting. It has been enriched so physicians can interact with images from the massive data sets being generated by today's CT and MR systems. The software can handle data sets that include more than 1 GB of medical images, according to the company.
The 3viseon software is based on graphics processing unit (GPU) architecture that is faster and more programmable than that of standard computer central processing units. By shifting graphics operations to the GPU, the software blends 2D and 3D in an integrated environment. Physicians can avoid navigating between two different applications and user interfaces and slip seamlessly into 3D visualization.
The software may be used independently in a stand-alone setting or with existing PACS. Off-the-shelf adapters are available for integrating 3viseon software with PACS from major vendors, such as GE RadWorks/Centricity and Rogan viewPro. It also can be integrated within healthcare portals both within and outside the radiology department, including Stentor iSite, Ashvins, and Mirador.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.